Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. - Ryan DH; Fitch A; Kushner RF; Tronieri JS; Still CD; Apovian CM (Obesity science & practice, 2026)